Cathy Galbraith, Ph.D., es coautora correspondiente de un nuevo estudio en Nature Methods que presenta una serie de tintes fluorescentes que facilitan mucho la obtención de imágenes ultra detalladas de células vivas. (OHSU/Christine Torres Hicks)

A team at Oregon Health & Science University last month became the first center in the Pacific Northwest to perform a new procedure involving the targeted delivery of high-dose chemotherapy to the liver. (OHSU)

Patient Christine "Chris" Lines and Khashayar Farsad, M.D., Ph.D. A team at Oregon Health & Science University last month became the first center in the Pacific Northwest to perform a new procedure involving the targeted delivery of high-dose chemotherapy to the liver. (OHSU)

David Huang, M.D., Ph.D., co-invented the biomedical imaging technology known as optical coherence tomography, or OCT, and is the associate director and director of research at Oregon Health & Science University’s Casey Eye Institute. (OHSU)

David Huang, M.D., Ph.D., co-invented the biomedical imaging technology known as optical coherence tomography, or OCT, and is the associate director and director of research at Oregon Health & Science University’s Casey Eye Institute. (OHSU)

El Dr. David Huang, Ph.D., coinventó la tecnología de imagenología biomédica conocida como tomografia de coherencia óptica (siga en inglés, OCT) y es director asociado y director de investigación del Casey Eye Institute de la Oregon Health & Science University. (OHSU)